Skip to content

Sera Prognostics SERA Accrued expenses and other liabilities

Accrued expenses and other liabilities at other companies

NeoGenomics logo
NeoGenomicsNEO

Other financials

Income statement

See full
Revenue$14.0K-63.2%
Operating income-$9.4M-1.2%
Net income-$8.4M-2.6%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$4.2M-20.2%
Total debt$2.5M+286%
Total equity$67.6M-28.7%
Total assets$93.5M-20.8%

Cash flow

See full
Operating cash flow-$8.8M-16.2%
CapEx$8.0K+167%
Free cash flow-$8.8M-16.2%

Valuation

See full
Market cap$71.27M+5.0%
Enterprise value$69.6M+9.6%
P/S1,250.3×+622×

Profitability

See full
Operating margin-64,235.1%-8,092,342pp
Net margin-56,386%+1,586,573pp
FCF margin-48,377.2%-673,104pp

Returns & leverage

See full
Return on equity-39.6%-1.6pp
Debt / equity0.0×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by Sera Prognostics in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.

The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sera Prognostics's accrued expenses and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sera Prognostics's accrued expenses and other liabilities?
Sera Prognostics (SERA) reported accrued expenses and other liabilities of $2.34M in Q1 2026.
How has Sera Prognostics's accrued expenses and other liabilities changed year-over-year?
Sera Prognostics's accrued expenses and other liabilities increased by 23.8% year-over-year, from $1.89M to $2.34M.
What is the long-term trend for Sera Prognostics's accrued expenses and other liabilities?
Over 5 years (2020 to 2025), Sera Prognostics's accrued expenses and other liabilities has grown at a 13.8% compound annual growth rate (CAGR), from $1.58M to $3.01M.